Manulife (Manufacturers Life Insurance)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-15,379
| Closed | -$104K | – | 3217 |
|
2022
Q1 | $104K | Sell |
15,379
-3,870
| -20% | -$26.3K | ﹤0.01% | 2954 |
|
2021
Q4 | $161 | Sell |
19,249
-535
| -3% | -$4 | ﹤0.01% | 2968 |
|
2021
Q3 | $147K | Buy |
+19,784
| New | +$147K | ﹤0.01% | 3069 |
|
2021
Q2 | – | Sell |
-11,555
| Closed | -$119K | – | 3320 |
|
2021
Q1 | $119K | Buy |
+11,555
| New | +$119K | ﹤0.01% | 3026 |
|
2020
Q4 | – | Sell |
-11,765
| Closed | -$96K | – | 3043 |
|
2020
Q3 | $96K | Hold |
11,765
| – | – | ﹤0.01% | 2804 |
|
2020
Q2 | $86K | Buy |
11,765
+148
| +1% | +$1.08K | ﹤0.01% | 2795 |
|
2020
Q1 | $55K | Buy |
+11,617
| New | +$55K | ﹤0.01% | 2726 |
|
2018
Q3 | – | Sell |
-1,005
| Closed | -$8K | – | 4009 |
|
2018
Q2 | $8K | Sell |
1,005
-10,824
| -92% | -$86.2K | ﹤0.01% | 3972 |
|
2018
Q1 | $264K | Sell |
11,829
-825
| -7% | -$18.4K | ﹤0.01% | 2806 |
|
2017
Q4 | $161K | Buy |
12,654
+503
| +4% | +$6.4K | ﹤0.01% | 3174 |
|
2017
Q3 | $189K | Buy |
12,151
+12,032
| +10,111% | +$187K | ﹤0.01% | 3027 |
|
2017
Q2 | $2K | Buy |
+119
| New | +$2K | ﹤0.01% | 4153 |
|